Outcomes Of The TOURMALINE-MM3 Study
Robert Rifkin, MD, Hematologist/Oncologist, Associate Chair, US Oncology Hematology Research, Rocky Mountain Cancer Centers, discusses Outcomes Of The TOURMALINE-MM3 Study. At The 60th ASH Annual Meet...
Author: obr
Added: 01/15/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts